Aneta Pharmaceuticals Private Limited
Manufacturer of generic medicine with a wide range of products.
2022 | Ahmedabad, Gujarat (India) | Active
Aneta Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.50 Cr
- Paid Up Capital ₹ 4.50 Cr
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 30.85 Cr
- Revenue Growth 174.28%
- Profit Growth -11527.71%
- Ebitda -16059.63%
- Net Worth -141.94%
- Total Assets 182.54%
About Aneta Pharmaceuticals
Aneta Pharmaceuticals Private Limited (APPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 04 May 2022 (Two years and ten months 5 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 4.50 Cr.
The company currently has active open charges totaling ₹30.85 Cr.
Nitin Patel, Subhash Chhabhaiya, and Rameshbhai Patel serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230GJ2022PTC131644
- Company No.
131644
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 May 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Pharma
Who are the key members and board of directors at Aneta Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Patel  | Director | 04-May-2022 | Current |
| Subhash Chhabhaiya | Director | 04-May-2022 | Current |
| Rameshbhai Patel | Director | 18-Aug-2022 | Current |
Financial Performance of Aneta Pharmaceuticals.
Aneta Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 174.28% increase. The company also saw a substantial fall in profitability, with a 11527.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 141.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aneta Pharmaceuticals?
In 2024, Aneta Pharmaceuticals had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indo Smc LimitedNitin Patel is a mutual person
Accent Microcell LimitedNitin Patel is a mutual person
- Globe Star Valves Private Limited
Nitin Patel is a mutual person
- Indocon Infrastructure Private Limited
Subhash Chhabhaiya is a mutual person
Charges (Loans)
Open Charges
₹30.85 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 30.85 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jan 2024 | Hdfc Bank Limited | ₹1.85 M | Open |
| 30 Sep 2022 | Hdfc Bank Limited | ₹30.67 Cr | Open |
How Many Employees Work at Aneta Pharmaceuticals?
Aneta Pharmaceuticals has a workforce of 188 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aneta Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aneta Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Aneta Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Aneta Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge with Hdfc Bank Limited of Rs. 30.67 Cr registered on 30 Sep 2022 with Charge ID 100624900 was modified on 26 Jul 2024.
- Balance Sheet
Aneta Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 100848483 was registered on 04 Jan 2024.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 30.67 Cr with Charge ID 100624900 was registered on 30 Sep 2022.
- Director Appointment
Rameshbhai Khimjibhai Patel was appointed as a Director was appointed as a Director on 18 Aug 2022 & has been associated with this company since 2 years 6 months .
Frequently asked questions
What is the Incorporation or founding date of Aneta Pharmaceuticals Private Limited?
Aneta Pharmaceuticals Private Limited was incorporated on 04 May 2022.
What is authorized share capital and paid-up capital of Aneta Pharmaceuticals Private Limited?
The authorized share capital of Aneta Pharmaceuticals Private Limited is ₹ 4.50 Cr and paid-up capital is ₹ 4.50 Cr.
Who are the current board members & directors of Aneta Pharmaceuticals Private Limited?
Currently 3 directors are associated with Aneta Pharmaceuticals Private Limited.
- Nitin Jasvantbhai Patel
- Subhash Jayantibhai Chhabhaiya
- Rameshbhai Khimjibhai Patel
What is the registered address of Aneta Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Aneta Pharmaceuticals Private Limited is 808 Shilp Zaveri, Shyamal Cross Road Satelite India, Ahmedabad, Gujarat, 380015.
What is the corporate identification number (CIN) and company number of Aneta Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Aneta Pharmaceuticals Private Limited is U24230GJ2022PTC131644 and the company number is 131644 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Aneta Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Aneta Pharmaceuticals Private Limited has risen by 174.28%.
How many employees does Aneta Pharmaceuticals Private Limited currently have?
As Per 2024 financial reports, 188 employees are currently employed by Aneta Pharmaceuticals Private Limited.
What change has been observed in the net worth of Aneta Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Aneta Pharmaceuticals Private Limited has experienced an downturn of -141.94%.
What are the total open charges for Aneta Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Aneta Pharmaceuticals Private Limited amount to ₹ 30.85 Cr.
When was the last Balance Sheet of Aneta Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Aneta Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.